While these agents can effectively suppress inflammation through mechanisms like cyclooxygenase-2 (COX-2) inhibition or immune modulation, their long-term use is frequently associated with adverse effects, such as gastrointestinal toxicity, cardiovascular complications, drug resistance, increased risk of infections, and systemic immunosuppression [2]. The gene discussed is PTGS2; the disease is infection.